VEVADEQ Trademark

Trademark Overview


On Wednesday, February 9, 2022, a trademark application was filed for VEVADEQ with the United States Patent and Trademark Office. The USPTO has given the VEVADEQ trademark a serial number of 97260150. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, April 10, 2024. This trademark is owned by Pfizer Inc.. The VEVADEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy
vevadeq

General Information


Serial Number97260150
Word MarkVEVADEQ
Filing DateWednesday, February 9, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, April 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 10, 2024SOU EXTENSION 2 FILED
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Saturday, October 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 5, 2023SOU EXTENSION 1 GRANTED
Thursday, October 5, 2023SOU EXTENSION 1 FILED
Thursday, October 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 12, 2022NEW APPLICATION ENTERED